While we found no significant differences in these respiratory mediators by disease group, others have found higher levels of Eotaxin and IFNγ in COPD and higher levels of IL‐5 and MCP‐4 in CRS, particularly those with nasal polyps, compared to healthy controls (Stevens et al., 2015). This evidence concerns the gene IL5 and congenital rubella syndrome.